Machine learning meets su(n) Lie algebra: Enhancing quantum dynamics learning with exact trace conservation
Abstract
Machine learning has emerged as a promising tool for simulating quantum dissipative dynamics. However, existing methods often struggle to enforce key physical constraints, such as trace conservation, when modeling reduced density matrices (RDMs). While physics-informed neural networks (PINN) aim to address these challenges, they frequently fail to achieve full physical consistency. In this work, we introduce a novel approach that leverages the su(n) Lie algebra to represent RDMs as a combination of an identity matrix and n2 - 1 Hermitian, traceless, and orthogonal basis operators, where n is the system's dimension. By learning only the coefficients associated with the operators, our framework inherently ensures exact trace conservation, as the traceless nature of the operators restricts the trace contribution solely to the identity matrix. This eliminates the need for explicit trace-preserving penalty terms in the loss function, simplifying optimization and improving learning efficiency. We validate our approach on two benchmark quantum systems: the spin-boson model and the Fenna-Matthews-Olson complex. By comparing the performance of four neural network architectures-purely data-driven physics-uninformed neural networks (PUNN), su(n) Lie algebra-based PUNN (su(n)-PUNN), traditional PINN, and su(n) Lie algebra-based PINN (su(n)-PINN)-we highlight the limitations of conventional methods and demonstrate the superior accuracy, robustness, and efficiency of our approach in…
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.